Target intelligence / Profile preview

Immunoglobulin lambda variable (I)-63 (pseudogene) (IGLVI-63)

Target
IGLVI-63
Molecular classification
Pseudogene, Immunoglobulin lambda variable region family
01

Overview

Immunoglobulin lambda variable (I)-63, abbreviated as IGLVI-63, refers to a pseudogene in the immunoglobulin lambda light chain variable region locus[7][5][3]. Immunoglobulin genes (which include both functional and pseudogenes) typically encode components of antibodies that are central to antigen recognition and immune response[1][4]. However, IGLVI-63 itself is classified as a pseudogene, meaning it is a DNA segment homologous to a functional gene but incapable of encoding a functional immunoglobulin protein; hence, it does not participate in biological processes, therapeutic targeting, or disease pathology[7][3][5]. Functional immunoglobulin lambda variable genes provide diversity for antibody binding through recombination events in B-cells and are critical to immune function[1][4][6], but IGLVI-63 does not contribute to this diversity due to its nonfunctional status[3][7][5]. If the query aims to find potential drug/clinical utility, there is none specific to this pseudogene. Functional immunoglobulin lambda variable genes (e.g., IGLV6-57, IGLV2-14) do participate in antigen recognition as part of immune responses and are sometimes implicated in disease and therapy, but IGLVI-63 is not among these functionally active genes[1][6][8].

Other names
IGLVI-63IGLV(I)-63IGLVI63V1-24PIGLVI-63 (all are variants in database entries or gene nomenclature)

Beyond the preview

Go deeper on Immunoglobulin lambda variable (I)-63 (pseudogene) (IGLVI-63).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable (I)-63 (pseudogene) (IGLVI-63).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call